FI
FIORF.US Fiore Cannabis Ltd
- Market cap
- USD 19.7K
- P/E
- -
- P/B
- 0.95x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2022.
Is FIORF.US undervalued?
Graham numberThe Graham number of Fiore Cannabis Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Fiore Cannabis Ltd fundamental analysis
No fundamental analysis for Fiore Cannabis Ltd yet.
Fiore Cannabis Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Fiore Cannabis Ltd
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020. The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
Full company profileFiore Cannabis Ltd financial statements
2022 annualized: Fiscal year 2022 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2022, the balance sheet is the latest quarter. Figures change when the annual report is published.
Fiore Cannabis Ltd annual financial statements
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | - | - | - | 384K | 156K | 1.46M | 2.27M | - | 3.15M | 1.54M |
| Gross Profit | - | - | - | - | 384K | 62.9K | 572K | 549K | - | 711K | -958K |
| Operating Income | -52.1K | -56.6K | -296K | -2.51M | -9.77M | -17.7M | -21.8M | -10.9M | - | -5.73M | -4.57M |
| EBITDA | -52.1K | -56.6K | -276K | -2.50M | 217K | 677K | 4.19M | 14.9M | - | -4.91M | -3.78M |
| Net Income | -52.1K | 30.3K | -4.63M | -3.30M | -9.99M | -20.7M | -29.4M | -40.0M | - | -8.85M | -6.11M |
| EPS | -0.01 | 0.04 | -0.68 | -0.36 | -0.72 | -0.89 | -0.65 | -0.43 | - | -0.06 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | 585K | 397K | 1.19M | 1.17M | 12.6M | 24.9M | 48.7M | 36.0M | - | 17.4M | 17.6M |
| Total Liabilities | 54.4K | 24.1K | 101K | 860K | 1.97M | 3.33M | 12.2M | 18.3M | - | 17.8M | 18.6M |
| Shareholders' Equity | 531K | -24.1K | 1.09M | 307K | 10.7M | 21.6M | 36.6M | 17.6M | - | -341K | -1.01M |
| Cash & Short-term Investments | 302K | 97.0K | 349K | 330K | 4.32M | 815K | 107K | 49.0K | - | 281K | 49.0K |
| Total Debt | - | - | - | 393K | 1.33M | 997K | 6.43M | 5.35M | - | 13.6M | 14.1M |
| Cash Flow | |||||||||||
| Operating Cash Flow | - | 86.8K | -221K | -613K | -5.77M | -5.57M | -12.3M | -2.63M | -3.42M | -3.49M | -750K |
| Capital Expenditure | 56.0K | 22.0K | 14.3K | 920K | 3.03M | 13.1M | 11.7M | 1.12M | 359K | 554K | 230K |
| Free Cash Flow | - | 86.8K | -235K | -1.53M | -8.81M | -18.7M | -24.1M | -3.75M | - | -4.04M | -980K |
| Ratios | |||||||||||
| ROE | -9.8% | - | -423.5% | -1,073.8% | -93.6% | -96.1% | -80.4% | -226.6% | - | - | - |
| ROA | -8.9% | 7.6% | -387.5% | -282.3% | -79.0% | -83.2% | -60.4% | -111.1% | - | -50.7% | -34.7% |
| Net Profit Margin | - | - | - | - | -2,601.6% | -13,315.7% | -2,015.3% | -1,761.9% | - | -280.9% | -398.0% |
| Debt to Equity | - | - | - | 1.28x | 0.13x | 0.05x | 0.18x | 0.30x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Fiore Cannabis Ltd dividends
Fiore Cannabis Ltd has not paid dividends in the last 9 fiscal years.
Last stock split: 1:4 on Jun 12, 2019.
Who owns Fiore Cannabis Ltd
- Insiders 0.86%
- Institutions 0.00%
- Public & others 99.14%
- Shares outstanding 197M
- Free float 179M
Fiore Cannabis Ltd company profile
- Company name
- Fiore Cannabis Ltd
- Ticker
- FIORF.US
- Exchange
- USA Stocks
- Listed since
- Nov 16, 1998
- Sector
- Healthcare
- Industry
- Metals & Mining
- Fiscal year end
- December
- Address
- RPO Orchard Park, Kelowna, BC, Canada, V1Y 9N8
- Phone
- 778 583 4476
- Website
- fiorecannabis.com
About Fiore Cannabis Ltd
Fiore Cannabis Ltd. cultivates, produces, and distributes medical and recreational marijuana in the United States. It also operates dispensary in California. The company was formerly known as Citation Growth Corp. and changed its name to Fiore Cannabis Ltd. in October 2020. The company was incorporated in 2007 and is headquartered in Kelowna, Canada.
Fiore Cannabis Ltd management
4- Mr. Marcel Rene LeBlancChairman & Interim CEO
- Mr. Kevin CornishChief Financial Officer & Director
- Mr. David EvelynChief Operating Officer
- Mr. James O'SullivanCorp. Sec.